While much prior work has focused on the hepatic acute-phase SAA1 and SAA2 subtypes, important roles for extra-hepatic SAA in the chronic inflammatory processes associated with metabolic diseases are now emerging (82, 83). This evidence concerns the gene SAA1 and metabolic disease.